BBA
BLRX

Baader Bank Aktiengesellschaft’s BioLineRX BLRX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-331
Closed -$5.09K – 396
2024
Q3 		$5.09K Buy
+331
New +$9.09K ﹤0.01% 419

Other funds holding BLRX

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
OGF
Orin Green Financial San Diego, California $271M AUM 20.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Baader Bank Aktiengesellschaft's BLRX Position: Q4 2024 in Review

Baader Bank Aktiengesellschaft sold out of BioLineRX (BLRX) in Q4 2024, closing a stake of 331 shares — an estimated $5.09K sold.

Baader Bank Aktiengesellschaft first reported a position in BLRX in Q3 2024 and held it in 1 quarter. The position peaked at $5.09K in Q3 2024. 31 funds tracked by Wall St. Rank hold BLRX as of Q4 2024.

  • Baader Bank Aktiengesellschaft reported no remaining BioLineRX position as of Q4 2024 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 331 BioLineRX shares in Q4 2024, an estimated $5.09K.
  • Baader Bank Aktiengesellschaft first reported a position in BioLineRX in Q3 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's BioLineRX position peaked at $5.09K in Q3 2024.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q4 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2024, filed 23 Jan 2025.